Form 8-K - Current report:
SEC Accession No. 0001558370-25-000035
Filing Date
2025-01-06
Accepted
2025-01-06 16:45:15
Documents
16
Period of Report
2025-01-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20250106x8k.htm   iXBRL 8-K 57031
2 EX-99.1 gbio-20250106xex99d1.htm EX-99.1 14101
3 GRAPHIC gbio-20250106xex99d1001.jpg GRAPHIC 5297
  Complete submission text file 0001558370-25-000035.txt   209854

Data Files

Seq Description Document Type Size
4 EX-101.SCH gbio-20250106.xsd EX-101.SCH 4034
5 EX-101.DEF gbio-20250106_def.xml EX-101.DEF 2734
6 EX-101.LAB gbio-20250106_lab.xml EX-101.LAB 13966
7 EX-101.PRE gbio-20250106_pre.xml EX-101.PRE 10832
18 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20250106x8k_htm.xml XML 4614
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 25511879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)